Cancer Biomarkers: Used for Early Detection of Possible Recurrent Disease

The new Cancer Biomarkers Industry Report has been published today. It provides updated in 2018 year analysis of healthcare technology Industries.

Market Definition:

The global cancer biomarkers market size was valued at USD 10.27 Billion in 2016 and is expected to reach USD 26.80 Billion in 2025, growing at a CAGR of over 11.35% over the forecast period. Increasing demand for cancer detection techniques and requirement of high-speed noninvasive diagnosis using genomics and proteomics are a few drivers of this market.

A biological molecule that can be found in blood, other body fluids or tissues indicating the normalcy or abnormality of any biological process, or of a disease/condition etc. is called a biomarker. Cancer biomarkers are molecules, substances or processes that can indicate the presence of cancers in body. Biomarkers are either secreted by the cancer tissues themselves or are produced as a response to cancer by other cells in the body. They are present in urine, blood, tumor tissue, stool, other tissues or bodily fluids. Myriad of pharmaceutical and biotech companies employ biomarkers during their drug discovery and developmental process. This helps company’s strategic alliances for sharing technology for biomarker applications during large-stage clinical trials which is fueling the growth of this market.

Get PDF with Technological trends at https://www.xpodenceresearch.com/Request-Sample/106916

Market Analysis with Latest Growth Factors:

On the basis of cancer type, the cancer biomarker is classified into breast, multiple myeloma, melanoma, thyroid, liver, prostate, lung, leukemia, colorectal, central nervous system (CNS), bladder, gastric, kidney, and other cancers, such as cervical, non-Hodgkin’s lymphoma, pharynx, pancreatic, oral cavity, stomach and ovarian cancers.

Breast cancer is anticipated to account for the maximum share in the global cancer biomarkers market. Increased focus of key companies on developing novel diagnostic assays is an essential driver for the growth of this market. Globally, numerous initiatives are being organized in order to increase the awareness of breast cancer ensuring early detection of the condition, thereby adding to the number of diagnostic scans. This factor is anticipated to drive market growth in this segment.

Major Key Players:

Some of the major players in the cancer biomarkers market are Merck, Abbott, Agilent, Roche, Hologic, Illumina , Becton Dickinson, Affymetrix, Thermo Fisher, and QIAGEN.

Market Segmentation:

Based on the type of biomarker, the cancer biomarkers market is segregated into genetic biomarker, protein biomarker and other biomarkers. Among these, the protein biomarkers segment is anticipated to dominate the global cancer biomarkers market which can be attributed to the monumental potential of protein biomarkers in detection of cancer, cancer diagnostics, prognostics, and therapeutic & clinical applications. Moreover, unlike steep costs of genetic biomarker tests, protein biomarker tests have low costs. Additionally, key pharmaceutical companies are majorly focused towards discovering protein biomarkers and are anticipated to augment the market during the forecast period.

Obtain Report Details with technological advancement at https://www.xpodenceresearch.com/Reports/Cancer-Biomarkers-Market

Region Analysis:

The North American region holds the largest market share of the global cancer biomarkers market in 2017 which can be mainly attributed to favorable government policies and increased governmental support in the R&D of biomarkers. Furthermore, surge in the demand for personalized medicine, adoption of advanced omics technologies for discovery of biomarkers and increased use of biomarkers in drug development and discovery by pharmaceutical companies in that region also aids to the inflating market growth.

Major Points from Table of content:

  • Executive Summary
  • Research Methodology
  • Market Dynamics
  • Industry Overview
  • Global Cancer Biomarkers Market, By Product (2017-2025)
  • Global Cancer Biomarkers Market, By Regions (2017-2025)
  • Market Competition Analysis

About Us:

Xpodence Research have the most extensive collection of market research reports of many categories. Xpodence Research provides the best market research solution for every industry by publishing the best possible results of great market research firms worldwide. For every particular problem, there’s a particular solution, so according to the customer needs, we provide the best possible results to them from different market research organization, whether it’s a Custom Research or Syndicated Research reports because the product that wins is the one that bridges customers to the future, not the one that requires a giant leap.

Every organization, whether it is related to Pharmaceuticals, Technology, Eatables, Consumable Goods and many more demands a market research results so that they can take important decisions for more productivity and better output in this swift world. Xpodence Research gives the best possible outcome, perfect forecast, analysis and insights of market research in the form of report which is beneficial for various organizations and also to the manufacturing companies in taking the best decisions for quality production.

Contact Us:

Xpodence Research

244, Madison Avenue

New York City, NY – 10016

United States

Toll Free +1- 844-445-2861

Email: sales@xpodenceresearch.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.